These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4581733)

  • 1. [Properties of toxins present in the spores of the Clostridium genus with special reference to Cl. botulinum].
    Rymkiewicz D
    Postepy Hig Med Dosw; 1973; 27(4):407-31. PubMed ID: 4581733
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of Clostridium botulinum type E in smoked fish.
    Kautter DA; Lilly T
    J Assoc Off Anal Chem; 1971 Sep; 54(5):1039. PubMed ID: 4948812
    [No Abstract]   [Full Text] [Related]  

  • 3. [Production of botulinum toxin in preserved fruits].
    de Lagarde A; Beerens H
    Ann Inst Pasteur Lille; 1970; 21():231-53. PubMed ID: 4948882
    [No Abstract]   [Full Text] [Related]  

  • 4. [Soluble proteins of the vegetative cells and spores of Clostridium botulinum type B and their toxicity].
    Nikolaeva SA
    Prikl Biokhim Mikrobiol; 1976; 12(3):449-53. PubMed ID: 792871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serological properties of the soluble spore antigens of Clostridium botulinum].
    Rymkiewicz D
    Med Dosw Mikrobiol; 1971; 23(4):313-9. PubMed ID: 5003807
    [No Abstract]   [Full Text] [Related]  

  • 6. Presence of Clostridium botulinum spores in Matricaria chamomilla (chamomile) and its relationship with infant botulism.
    Bianco MI; Lúquez C; de Jong LI; Fernández RA
    Int J Food Microbiol; 2008 Feb; 121(3):357-60. PubMed ID: 18068252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Clostridium botulinum type A: release of toxin from C. botulinum spores in vitro by leucocytes.
    Suzuki JB; Booth RR; Grecz N
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):691-711. PubMed ID: 4944551
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular structures and biological activities of Clostridium botulinum toxins.
    Sakaguchi G; Oishi I; Kozaki S; Sakaguchi S; Kitamura M
    Jpn J Med Sci Biol; 1974 Apr; 27(2):95-9. PubMed ID: 4601038
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
    Reiss J; Wojtyła B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C2 toxicity in extract of Clostridium botulinum type C spores.
    Yamakawa K; Nishida S; Nakamura S
    Infect Immun; 1983 Aug; 41(2):858-60. PubMed ID: 6347900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence and mobility of a Clostridium botulinum spore population introduced to soil with spiked compost.
    Gessler F; Böhnel H
    FEMS Microbiol Ecol; 2006 Dec; 58(3):384-93. PubMed ID: 17117983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum toxin in mixed cultures of sporulating anaerobes].
    Mierzejewski J; Skoczek A
    Med Dosw Mikrobiol; 1977; 29(3):211-7. PubMed ID: 336998
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis of Clostridium botulinum intoxication].
    Mölle G; Hentschke J
    Dtsch Tierarztl Wochenschr; 1999 Feb; 106(2):73. PubMed ID: 10085583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular construction and biological activities of botulinum toxins (author's transl)].
    Sakaguchi G; Ohishi I
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():45-54. PubMed ID: 800282
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of leukocyte metabolism to Clostridium botulinum pathogenicity.
    Suzuki JB; Benedik A; Grecz N
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):633-48. PubMed ID: 4945072
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
    Ligieza J; Michalik M; Reiss J; Grzybowski J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):189-95. PubMed ID: 2431667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of RNA species in the RNA-toxin complex and structure of the complex in Clostridium botulinum type E.
    Kitamura M
    Biochem Biophys Res Commun; 2002 Feb; 291(1):154-7. PubMed ID: 11829476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparative separation of toxin and prototoxin from CL. botulinum type B cells].
    Ivanova LG; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):115-8. PubMed ID: 4218008
    [No Abstract]   [Full Text] [Related]  

  • 20. Hazard and control of group II (non-proteolytic) Clostridium botulinum in modern food processing.
    Lindström M; Kiviniemi K; Korkeala H
    Int J Food Microbiol; 2006 Apr; 108(1):92-104. PubMed ID: 16480785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.